{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:49:35Z","timestamp":1740160175727,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetes Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s13300-024-01580-z","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T10:02:42Z","timestamp":1714125762000},"page":"1417-1434","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["An Analysis of the Distribution of Direct Cost of Diabetes Care in Selected Districts in Italy"],"prefix":"10.1007","volume":"15","author":[{"given":"Francesco Saverio","family":"Mennini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Sciattella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Marcellusi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Bartolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Futura","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fleur","family":"Levrat-Guillen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Di Gennaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Giordana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianna","family":"Giustozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugo","family":"Trama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"key":"1580_CR1","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.2337\/db13-1093","volume":"62","author":"DM Nathan","year":"2013","unstructured":"Nathan DM, Bayless M, Cleary P, et al. Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30\u00a0years: advances and contributions. Diabetes. 2013;62:3976\u201386.","journal-title":"Diabetes"},{"key":"1580_CR2","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","volume":"359","author":"RR Holman","year":"2008","unstructured":"Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HAW. 10-year follow-up of intensive glucose control in type\u00a02 diabetes. New Engl J Med. 2008;359:1577\u201389.","journal-title":"New Engl J Med"},{"key":"1580_CR3","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","author":"American Diabetes Association","year":"2018","unstructured":"American Diabetes Association. Economic costs of diabetes in the U.S. in 2017. Diabetes Care. 2018;41:917\u201328.","journal-title":"Diabetes Care"},{"key":"1580_CR4","doi-asserted-by":"publisher","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","volume":"64","author":"RIG Holt","year":"2021","unstructured":"Holt RIG, DeVries JH, Hess-Fischl A, et al. The management of type\u00a01 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2021;64:2609\u201352.","journal-title":"Diabetologia"},{"key":"1580_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2020-001191","volume":"8","author":"E Bonora","year":"2020","unstructured":"Bonora E, Cataudella S, Marchesini G, et al. Clinical burden of diabetes in Italy in 2018: a look at a systemic disease from the ARNO Diabetes Observatory. BMJ Open Diabetes Res Care. 2020;8:e001191. https:\/\/doi.org\/10.1136\/bmjdrc-2020-001191.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1580_CR6","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1016\/j.numecd.2020.08.018","volume":"30","author":"E Bonora","year":"2020","unstructured":"Bonora E, Cataudella S, Marchesini G, et al. A view on the quality of diabetes care in Italy and the role of Diabetes Clinics from the 2018 ARNO Diabetes Observatory. Nutr Metab Cardiovasc Dis. 2020;30:1945\u201353.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1580_CR7","unstructured":"Inglese SA. Disuguaglianze, territorio, prevenzione, un percorso ancora lungo: Seconda Indagine civica sul Diabete. 2021. https:\/\/www.cittadinanzattiva.it\/multimedia\/import\/files\/comunicati\/salute\/Seconda_Indagine_civica_sul_Diabete_Abstract_def.pdf. Accessed 27 Mar 2024."},{"key":"1580_CR8","unstructured":"Aprile V, Baldissera S, D\u2019Argenzio A, et al. I risultati nazionali dello studio QUADRI (QUalit\u00e0 dell\u2019Assistenza alle persone Diabetiche nelle Regioni Italiane). Roma: Istituto Superiore di Sanit\u00e0; 2007. (Rapporti ISTISAN 07\/10)."},{"issue":"1","key":"1580_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2016-000197","volume":"4","author":"A Marcellusi","year":"2016","unstructured":"Marcellusi A, Viti R, Sciattella P, et al. Economic aspects in the management of diabetes in Italy. BMJ Open Diabetes Res Care. 2016;4(1):e000197. https:\/\/doi.org\/10.1136\/bmjdrc-2016-000197.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1580_CR10","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s10198-014-0660-y","volume":"17","author":"A Marcellusi","year":"2016","unstructured":"Marcellusi A, Viti R, Mecozzi A, Mennini FS. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach. Eur J Health Econ. 2016;17:139\u201347.","journal-title":"Eur J Health Econ"},{"key":"1580_CR11","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee, Draznin B, Aroda VR, et al. 7. Diabetes Technology: Standards of Medical Care in Diabetes\u20142022. Diabetes Care. 2022;45:S97\u2013112.","DOI":"10.2337\/dc22-S007"},{"key":"1580_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s40200-015-0172-z","volume":"14","author":"JEF Ward","year":"2015","unstructured":"Ward JEF, Stetson BA, Mokshagundam SPL. Patient perspectives on self-monitoring of blood glucose: perceived recommendations, behaviors and barriers in a clinic sample of adults with type\u00a02 diabetes. J Diabetes Metab Disord. 2015;14:43. https:\/\/doi.org\/10.1186\/s40200-015-0172-z.","journal-title":"J Diabetes Metab Disord"},{"issue":"16","key":"1580_CR13","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","volume":"387","author":"L Leelarathna","year":"2022","unstructured":"Leelarathna L, Evans ML, Neupane S, et al. Intermittently scanned continuous glucose monitoring for type\u00a01 diabetes. N Engl J Med. 2022;387(16):1477\u201387.","journal-title":"N Engl J Med"},{"key":"1580_CR14","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1007\/s13300-021-01172-1","volume":"12","author":"J Jendle","year":"2021","unstructured":"Jendle J, Eeg-Olofsson K, Svensson A-M, Franzen S, Lamotte M, Levrat-Guillen F. Cost-effectiveness of the FreeStyle Libre\u00ae system versus blood glucose self-monitoring in individuals with type\u00a02 diabetes on insulin treatment in Sweden. Diabetes Ther. 2021;12:3137\u201352.","journal-title":"Diabetes Ther"},{"key":"1580_CR15","doi-asserted-by":"crossref","unstructured":"Nathanson D, Svensson A-M, Miftaraj M, Franz\u00e9n S, Bolinder J, Eeg-Olofsson K. Effect of flash glucose monitoring in adults with type\u00a01 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia. 2021;64:1595\u20131603.","DOI":"10.1007\/s00125-021-05437-z"},{"key":"1580_CR16","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","volume":"388","author":"J Bolinder","year":"2016","unstructured":"Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr\u00f6ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type\u00a01 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388:2254\u201363.","journal-title":"Lancet"},{"key":"1580_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","volume":"8","author":"T Haak","year":"2017","unstructured":"Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline J-P, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type\u00a02 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8:55\u201373.","journal-title":"Diabetes Ther"},{"issue":"6","key":"1580_CR18","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.2337\/dc20-1690","volume":"44","author":"R Roussel","year":"2021","unstructured":"Roussel R, Riveline J-P, Vicaut E, et al. Important drop in the rate of acute diabetes complications in people with type\u00a01 or type\u00a02 diabetes after initiation of flash glucose monitoring in France: the RELIEF study. Diabetes Care. 2021;44(6):1368\u201376.","journal-title":"Diabetes Care"},{"issue":"9","key":"1580_CR19","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1089\/dia.2022.0085","volume":"24","author":"J-P Riveline","year":"2022","unstructured":"Riveline J-P, Roussel R, Vicaut E, et al. Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study. Diabetes Technol Ther. 2022;24(9):611\u20138.","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"1580_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1089\/dia.2022.0271","volume":"25","author":"B Guerci","year":"2023","unstructured":"Guerci B, Roussel R, Levrat-Guillen F, et al. Important decrease in hospitalizations for acute diabetes events following FreeStyle Libre\u00ae system initiation in people with type\u00a02 diabetes on basal insulin therapy in France. Diabetes Technol Ther. 2023;25(1):20\u201330.","journal-title":"Diabetes Technol Ther"},{"key":"1580_CR21","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1001\/jama.2016.19975","volume":"317","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth T, Ruedy K, et al. Effect of continuous glucose monitoring on glycemic control in adults with type\u00a01 diabetes using insulin injections: the DIAMOND randomized clinical trial. JAMA. 2017;317:371\u20138.","journal-title":"JAMA"},{"key":"1580_CR22","doi-asserted-by":"publisher","first-page":"365","DOI":"10.7326\/M16-2855","volume":"167","author":"RW Beck","year":"2017","unstructured":"Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous glucose monitoring versus usual care in patients with type\u00a02 diabetes receiving multiple daily insulin injections. Ann Intern Med. 2017;167:365\u201374.","journal-title":"Ann Intern Med"},{"key":"1580_CR23","doi-asserted-by":"publisher","first-page":"2262","DOI":"10.1001\/jama.2021.7444","volume":"325","author":"T Martens","year":"2021","unstructured":"Martens T, Beck RW, Bailey R, et al. Effect of continuous glucose monitoring on glycemic control in patients with type\u00a02 diabetes treated with basal insulin. JAMA. 2021;325:2262\u201372.","journal-title":"JAMA"},{"key":"1580_CR24","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1177\/1932296814559746","volume":"9","author":"TS Bailey","year":"2015","unstructured":"Bailey TS, Chang A, Christiansen M. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol. 2015;9:209\u201314.","journal-title":"J Diabetes Sci Technol"},{"key":"1580_CR25","doi-asserted-by":"publisher","first-page":"854","DOI":"10.2337\/dc22-2189","volume":"46","author":"PD Reaven","year":"2023","unstructured":"Reaven PD, Newell M, Rivas S, Zhou X, Norman GJ, Zhou JJ. Initiation of continuous glucose monitoring is linked to improved glycemic control and fewer clinical events in type\u00a01 and type\u00a02 diabetes in the veterans health administration. Diabetes Care. 2023;46:854\u201363.","journal-title":"Diabetes Care"},{"key":"1580_CR26","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00592-023-02079-y","volume":"60","author":"J Mustonen","year":"2023","unstructured":"Mustonen J, Rautiainen P, Lamidi M-L, Lavikainen P, Martikainen J, Laatikainen T. The use of isCGM leads to marked reduction in severe hypoglycemia requiring emergency medical service or hospital admission and diabetic ketoacidosis in adult type\u00a01 diabetes patients. Acta Diabetol. 2023;60:891\u201398.","journal-title":"Acta Diabetol"},{"key":"1580_CR27","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.37765\/ajmc.2021.88780","volume":"27","author":"E Miller","year":"2021","unstructured":"Miller E, Kerr MSD, Roberts GJ, Nabutovsky Y, Wright E. Flash CGM associated with event reduction in nonintensive diabetes therapy. Am J Manag Care. 2021;27:e372\u20137.","journal-title":"Am J Manag Care"},{"key":"1580_CR28","first-page":"193","volume":"8","author":"RL Regina","year":"2020","unstructured":"Regina RL, Pandolfi D, Stabile N, et al. A new case manager for diabetic patients: a pilot observational study of the role of community pharmacists and pharmacy services in the case management of diabetic patients. Pharmacy (Basel). 2020;8:193.","journal-title":"Pharm"}],"container-title":["Diabetes Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01580-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13300-024-01580-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13300-024-01580-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T10:20:10Z","timestamp":1715768410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13300-024-01580-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1580"],"URL":"https:\/\/doi.org\/10.1007\/s13300-024-01580-z","relation":{},"ISSN":["1869-6953","1869-6961"],"issn-type":[{"type":"print","value":"1869-6953"},{"type":"electronic","value":"1869-6961"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"1 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Fleur Levrat-Guillen is employed by Abbott Diabetes Care. All other authors have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Internal review board approval was not sought as this analysis does not contain any studies with human participants or animals performed by any of the authors. Datasets were made available following the scientific agreement between CEIS (University of Tor Vergata) and Campania region\/ LHU Umbria 2. Exchange of data was compliant with the General Data Protection Regulation (EU) 2016\/679 (GDPR).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}